• LAST PRICE
    29.4300
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    28.9400/ 7
  • Ask / Lots
    28.9700/ 7
  • Open / Previous Close
    0.0000 / 29.4300
  • Day Range
    ---
  • 52 Week Range
    Low 26.3200
    High 42.9950
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 29.5
TimeVolumeGMAB
09:32 ET806528.98
09:36 ET25029.04
09:38 ET10029.02
09:39 ET110028.86
09:41 ET126228.81
09:43 ET299628.88
09:45 ET10028.84
09:50 ET10028.92
09:52 ET90028.95
09:54 ET220028.98
09:56 ET255628.975
09:57 ET244729.09
09:59 ET448129.03
10:01 ET10029.065
10:03 ET209429.07
10:06 ET41329.07
10:08 ET12629.08
10:10 ET61429.13
10:12 ET84029.13
10:14 ET10029.13
10:19 ET60129.16
10:24 ET57829.125
10:26 ET10029.12
10:28 ET115829.15
10:30 ET60029.16
10:32 ET10029.16
10:33 ET37329.16
10:35 ET560229.29
10:37 ET50029.27
10:39 ET10029.3
10:42 ET66029.31
10:44 ET187829.325
10:46 ET480429.24
10:48 ET80029.16
10:50 ET20029.16
10:51 ET70429.15
10:53 ET253829.18
10:57 ET30029.19
11:00 ET1067429.28
11:06 ET30029.3
11:08 ET80029.33
11:09 ET107629.335
11:11 ET20029.34
11:13 ET210129.39
11:15 ET303029.435
11:18 ET849329.45
11:20 ET367029.4691
11:22 ET62129.41
11:24 ET233029.46
11:26 ET194729.425
11:27 ET39629.44
11:29 ET30029.445
11:31 ET20029.44
11:33 ET110029.445
11:36 ET212629.43
11:38 ET30029.43
11:42 ET120029.43
11:44 ET15229.4355
11:45 ET52229.42
11:47 ET30029.41
11:49 ET131729.38
11:51 ET30029.397
11:54 ET30429.4201
11:56 ET56829.45
11:58 ET50029.44
12:00 ET60029.45
12:02 ET10029.44
12:03 ET150029.43
12:05 ET280029.44
12:07 ET10029.445
12:12 ET80429.47
12:14 ET40029.47
12:16 ET10029.47
12:18 ET80029.46
12:20 ET68629.47
12:21 ET40029.47
12:23 ET73129.47
12:25 ET80029.47
12:30 ET723629.51
12:32 ET90029.51
12:34 ET100029.53
12:36 ET130029.53
12:38 ET60029.54
12:39 ET184329.56
12:41 ET50029.57
12:43 ET221229.54
12:45 ET30729.55
12:48 ET20029.57
12:50 ET10029.565
12:52 ET50529.575
12:54 ET20029.58
12:56 ET30029.58
12:57 ET60029.57
12:59 ET10029.57
01:01 ET70029.59
01:03 ET109529.55
01:06 ET10029.56
01:08 ET23029.5553
01:10 ET40029.57
01:12 ET181229.57
01:14 ET30029.52
01:15 ET40029.53
01:17 ET115029.55
01:21 ET112029.58
01:24 ET81729.58
01:26 ET20029.58
01:28 ET82629.57
01:30 ET177829.54
01:32 ET70729.455
01:33 ET20029.47
01:35 ET60029.51
01:37 ET60029.51
01:39 ET117129.51
01:42 ET177729.52
01:44 ET30029.53
01:46 ET341529.54
01:48 ET60929.52
01:50 ET70029.52
01:51 ET10029.51
01:53 ET10029.51
01:55 ET30029.51
01:57 ET10029.52
02:00 ET97129.52
02:02 ET111229.5
02:04 ET160029.52
02:06 ET20029.53
02:08 ET10029.54
02:09 ET269429.595
02:11 ET151129.575
02:13 ET47729.58
02:15 ET92029.53
02:18 ET80429.51
02:20 ET30029.5
02:22 ET100029.46
02:24 ET10029.45
02:26 ET34029.45
02:27 ET118929.46
02:29 ET121029.46
02:31 ET90029.46
02:33 ET30029.46
02:36 ET352629.52
02:38 ET89529.49
02:40 ET35129.4901
02:42 ET60029.49
02:44 ET72029.5
02:45 ET48529.5
02:49 ET71729.51
02:51 ET99929.53
02:54 ET50029.57
02:58 ET198129.57
03:00 ET42029.58
03:02 ET90029.56
03:03 ET143929.54
03:05 ET60329.53
03:07 ET70029.53
03:09 ET80029.52
03:12 ET90029.55
03:14 ET138429.5445
03:16 ET261429.528
03:18 ET10029.51
03:21 ET75529.51
03:23 ET135029.5
03:25 ET80029.49
03:27 ET90529.5
03:30 ET68929.5001
03:32 ET50029.5
03:34 ET45329.46
03:36 ET212929.42
03:38 ET298729.44
03:39 ET74229.4699
03:41 ET100029.465
03:43 ET335129.47
03:45 ET170029.5
03:48 ET161229.46
03:50 ET90029.49
03:52 ET284529.47
03:54 ET1360629.44
03:56 ET234329.45
03:57 ET321729.43
03:59 ET473629.43
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGMAB
Genmab A/S
19.4B
31.3x
+22.71%
United StatesDNLI
Denali Therapeutics Inc
2.5B
-15.9x
---
United StatesMOR
MorphoSys AG
2.7B
-12.1x
---
United StatesIMCR
Immunocore Holdings PLC
2.6B
-47.2x
---
United StatesARWR
Arrowhead Pharmaceuticals Inc
2.9B
-8.5x
---
United StatesFOLD
Amicus Therapeutics Inc
3.1B
-20.5x
---
As of 2024-04-17

Company Information

Genmab A/S is a Denmark-based international biotechnology company. It specializes in the creation and development of antibody therapeutics for the treatment of cancer. The Company is the creator of the approved antibodies: DARZALEX (daratumumab) for the treatment of certain multiple myeloma indications, Kesimpta for the treatment of adults with relapsing forms of multiple sclerosis, TEPEZZA (teprotumumab) for the treatment of thyroid eye disease and FASPRO, for the treatment of adult patients with certain multiple myeloma indications. The first approved Genmab created therapy Arzerra, approved for the treatment of certain chronic lymphocytic leukemia indications, is available in Japan and is also available in other territories via compassionate use or oncology access programs. Genmab develops a broad clinical and pre-clinical product pipeline, and owns four antibody technologies, DuoBody bispecific platform, HexaBody platform, DuoHexaBody platform & HexElect platform.

Contact Information

Headquarters
Kalvebod Brygge 43KOEBENHAVN V, Denmark 1560
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Deirdre Connelly
President, Chief Executive Officer
Jan Van De Winkel
Independent Deputy Chairman of the Board
Pernille Erenbjerg
Chief Financial Officer, Executive Vice President
Anthony Pagano
Chief Operating Officer, Executive Vice President
Anthony Mancini

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$19.4B
Revenue (TTM)
$2.3B
Shares Outstanding
661.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.93
EPS
$0.94
Book Value
$6.89
P/E Ratio
31.3x
Price/Sales (TTM)
8.3
Price/Cash Flow (TTM)
---
Operating Margin
32.30%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.